Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension-Reference-Cited by-同舟云学术

Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension

Published:2022-01-03 Issue:2 Volume:29 Page:105-113
ISSN:1120-9879
Container-title:High Blood Pressure & Cardiovascular Prevention
language:en
Short-container-title:High Blood Press Cardiovasc Prev

Author:

Grassi Guido,Del Pinto Rita,Agabiti Rosei Claudia,Agnoletti Davide,Borghi Claudio,Cicero Arrigo F. G.,De Ciuceis Carolina,Desideri Giovambattista,Grassi Davide,Muiesan Maria Lorenza,Paini Anna,Salvetti Massimo,Tocci Giuliano,Veglio Franco,Volpe Massimo,Ferri Claudio

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40292-021-00501-6.pdf

Reference60 articles.

1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–22.

2. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356:2388–98.

3. Williams B, Masi S, Wolf J, Schmieder RE. Facing the challenge of lowering blood pressure and cholesterol in the same patient: report of a symposium at the European Society of Hypertension. Cardiol Ther. 2020;9:19–34.

4. Borghi C, Urso R, Cicero AF. Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia. Nutr Metab Cardiovasc Dis. 2017;27:115–20.

5. Koh KK, Sakuma I, Hayashi T, Kim SH, Chung W-J. Renin-angiotensin system inhibitor and statins combination therapeutics—what have we learnt? Expert Opin Pharmacother. 2015;16:949–53.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surface modification of polyetherimide/polyvinylpyrrolidone membranes via covalent grafting of heparin: in vitro evaluation of hemocompatibility;Brazilian Journal of Chemical Engineering;2023-12-11

2. STRUGGLE FOR. Włosko-polsko-hiszpańsko-uzbecko-wietnamskie Stanowisko Ekspertów 2023 dotyczące lepszej kontroli klasycznych modyfikowalnych czynników ryzyka w praktyce klinicznej;Choroby Serca i Naczyń;2023-12-05

3. Prevalence of Cardiovascular Risk Factors and Related Medical and Lifestyle Interventions Among Italian Cardiovascular Specialists: A Proof-of-Concept Study;High Blood Pressure & Cardiovascular Prevention;2023-05-08

4. Bempedoic Acid’s Use as an Adjunct in Lowering Low-Density Lipoprotein Cholesterol in Patients With Coronary Artery Disease: A Systematic Review;Cureus;2022-10-04

5. TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice;Cardiology Journal;2022-09-30